Aura Biosciences (NASDAQ:AURA) Receives Buy Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Aura Biosciences (NASDAQ:AURA – Free Report) in a research note released on Thursday morning,Benzinga reports. HC Wainwright currently has a $22.00 price target on the stock. A number of other research analysts have also recently commented on the company. Cowen reissued a “buy” rating on shares […]

Leave a Reply

Your email address will not be published.

Previous post Capricor Therapeutics (NASDAQ:CAPR) Price Target Raised to $30.00 at Cantor Fitzgerald
Next post KCM Investment Advisors LLC Sells 461 Shares of Tesla, Inc. (NASDAQ:TSLA)